Literature DB >> 22239849

Low concentrations of nicotine differentially desensitize nicotinic acetylcholine receptors that include α5 or α6 subunits and that mediate synaptosomal neurotransmitter release.

Sharon R Grady1, Charles R Wageman, Natalie E Patzlaff, Michael J Marks.   

Abstract

Desensitization is a complex property of nicotinic acetylcholine receptors (nAChR). Several subtypes of nAChR have high sensitivity to nicotine and mediate effects of nicotine at concentrations found in blood of tobacco smokers. Desensitization of some of these receptor subtypes has been studied in model systems, however, other subtypes have been difficult to express heterologously in native forms. In addition, model systems may not have the same accessory molecules and post-translational modifications found in native populations. We have used wild-type and subunit null mutant mice to study desensitization properties of the high sensitivity α4β2-nAChRs including those that have α5 subunits at both GABAergic and dopaminergic nerve terminals. In addition, we have studied the desensitization of one subtype of α6β2-nAChRs at dopaminergic terminals using α4 subunit null mutant mice. Exposure to low nicotine concentrations, leads to rapid, but partial desensitization of activity mediated by these receptors. α4β2-nAChRs including α5 subunits show faster rates of recovery from desensitization than α4β2-nAChRs without α5. Inclusion of the α5 subunit significantly shifts the concentration response for desensitization to higher values, indicating that receptors with α5 subunits are less desensitized by a 10-min exposure to low concentrations of nicotine. Receptors with α6 subunits appear to desensitize to a lesser degree than those with α4 subunits, indicating that α6β2-nAChRs are somewhat resistant to desensitization by nicotine. These results highlight the importance of studying various receptor subtypes in native systems and how they may differentially respond to nicotine and to nicotinic drugs.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22239849      PMCID: PMC3278500          DOI: 10.1016/j.neuropharm.2011.12.026

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  50 in total

1.  Acetylcholine receptor (AChR) α5 subunit variant associated with risk for nicotine dependence and lung cancer reduces (α4β2)₂α5 AChR function.

Authors:  Alexander Kuryatov; Wade Berrettini; Jon Lindstrom
Journal:  Mol Pharmacol       Date:  2010-09-29       Impact factor: 4.436

2.  Additional acetylcholine (ACh) binding site at alpha4/alpha4 interface of (alpha4beta2)2alpha4 nicotinic receptor influences agonist sensitivity.

Authors:  Simone Mazzaferro; Naïl Benallegue; Anna Carbone; Federica Gasparri; Ranjit Vijayan; Philip C Biggin; Mirko Moroni; Isabel Bermudez
Journal:  J Biol Chem       Date:  2011-07-14       Impact factor: 5.157

3.  Nicotinic alpha5 subunit deletion locally reduces high-affinity agonist activation without altering nicotinic receptor numbers.

Authors:  Robert W B Brown; Allan C Collins; Jon M Lindstrom; Paul Whiteaker
Journal:  J Neurochem       Date:  2007-06-15       Impact factor: 5.372

Review 4.  Differential contribution of genetic variation in multiple brain nicotinic cholinergic receptors to nicotine dependence: recent progress and emerging open questions.

Authors:  L Greenbaum; B Lerer
Journal:  Mol Psychiatry       Date:  2009-06-30       Impact factor: 15.992

Review 5.  Nicotinic modulation of synaptic transmission and plasticity in cortico-limbic circuits.

Authors:  Huibert D Mansvelder; Marjolijn Mertz; Lorna W Role
Journal:  Semin Cell Dev Biol       Date:  2009-01-22       Impact factor: 7.727

6.  Unraveling the high- and low-sensitivity agonist responses of nicotinic acetylcholine receptors.

Authors:  Kasper Harpsøe; Philip K Ahring; Jeppe K Christensen; Marianne L Jensen; Dan Peters; Thomas Balle
Journal:  J Neurosci       Date:  2011-07-27       Impact factor: 6.167

7.  Stable expression and functional characterization of a human nicotinic acetylcholine receptor with α6β2 properties: discovery of selective antagonists.

Authors:  Anna Maria Capelli; Laura Castelletti; Yu Hua Chen; Harjeet Van der Keyl; Luca Pucci; Beatrice Oliosi; Cristian Salvagno; Barbara Bertani; Cecilia Gotti; Andrew Powell; Manolo Mugnaini
Journal:  Br J Pharmacol       Date:  2011-05       Impact factor: 8.739

8.  Antidepressant-like effects of nicotinic acetylcholine receptor antagonists, but not agonists, in the mouse forced swim and mouse tail suspension tests.

Authors:  J T Andreasen; G M Olsen; O Wiborg; J P Redrobe
Journal:  J Psychopharmacol       Date:  2008-06-26       Impact factor: 4.153

Review 9.  Desensitization of nicotinic acetylcholine receptors as a strategy for drug development.

Authors:  Jerry J Buccafusco; J Warren Beach; Alvin V Terry
Journal:  J Pharmacol Exp Ther       Date:  2008-11-20       Impact factor: 4.030

10.  Gene targeting demonstrates that alpha4 nicotinic acetylcholine receptor subunits contribute to expression of diverse [3H]epibatidine binding sites and components of biphasic 86Rb+ efflux with high and low sensitivity to stimulation by acetylcholine.

Authors:  Michael J Marks; Natalie M Meinerz; John Drago; Allan C Collins
Journal:  Neuropharmacology       Date:  2007-06-07       Impact factor: 5.250

View more
  33 in total

1.  Long-term nicotine treatment down-regulates α6β2* nicotinic receptor expression and function in nucleus accumbens.

Authors:  Xiomara A Perez; J Michael McIntosh; Maryka Quik
Journal:  J Neurochem       Date:  2013-10-13       Impact factor: 5.372

2.  The additional ACh binding site at the α4(+)/α4(-) interface of the (α4β2)2α4 nicotinic ACh receptor contributes to desensitization.

Authors:  N Benallegue; S Mazzaferro; C Alcaino; I Bermudez
Journal:  Br J Pharmacol       Date:  2013-09       Impact factor: 8.739

3.  Nicotine and Resting-State Functional Connectivity: Effects of Intermittent Doses.

Authors:  Wei Huang; Kelly Tam; Janaque Fernando; Meghan Heffernan; Jean King; Joseph R DiFranza
Journal:  Nicotine Tob Res       Date:  2015-02-02       Impact factor: 4.244

4.  Postsynaptic nicotinic acetylcholine receptors facilitate excitation of developing CA1 pyramidal neurons.

Authors:  Beryl Y T Chung; Warren Bignell; Derek L Jacklin; Boyer D Winters; Craig D C Bailey
Journal:  J Neurophysiol       Date:  2016-08-03       Impact factor: 2.714

5.  Anxiolytic-like and anxiogenic-like effects of nicotine are regulated via diverse action at β2*nicotinic acetylcholine receptors.

Authors:  S M Anderson; D H Brunzell
Journal:  Br J Pharmacol       Date:  2015-03-24       Impact factor: 8.739

6.  Effectiveness of nicotinic agonists as desensitizers at presynaptic α4β2- and α4α5β2-nicotinic acetylcholine receptors.

Authors:  Charles R Wageman; Michael J Marks; Sharon R Grady
Journal:  Nicotine Tob Res       Date:  2013-09-19       Impact factor: 4.244

7.  Comparison of effects produced by nicotine and the α4β2-selective agonist 5-I-A-85380 on intracranial self-stimulation in rats.

Authors:  Kelen Freitas; F Ivy Carroll; S Stevens Negus
Journal:  Exp Clin Psychopharmacol       Date:  2016-02       Impact factor: 3.157

Review 8.  Unraveling the neurobiology of nicotine dependence using genetically engineered mice.

Authors:  Astrid K Stoker; Athina Markou
Journal:  Curr Opin Neurobiol       Date:  2013-03-29       Impact factor: 6.627

9.  Nicotine Dependence Reveals Distinct Responses from Neurons and Their Resident Nicotinic Receptors in Medial Habenula.

Authors:  Pei-Yu Shih; J Michael McIntosh; Ryan M Drenan
Journal:  Mol Pharmacol       Date:  2015-10-01       Impact factor: 4.436

10.  A role for α4(non-α6)* nicotinic acetylcholine receptors in motor behavior.

Authors:  Lindsey G Soll; Sharon R Grady; Outi Salminen; Michael J Marks; Andrew R Tapper
Journal:  Neuropharmacology       Date:  2013-05-17       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.